1516P Health-related quality of life (hrqol) analysis from KEYNOTE-859: First-line (1L) pembrolizumab (pembro) + chemotherapy (chemo) for advanced HER2-negative gastric or gastroes... von Lowery, M., Wyrwicz, L., Oh, D-Y., Shiu, K-K., Yanez Weber, P., Bai, Y., Lee, J., Rivera, F., Alves, G., Garrido, M., González Fernández, M., Li, J., Cil, T., Cruz, F., Qin, S., Yin, L., Valderrama, A., Bordia, S., Rha, S.Y.

Volltext

Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana von Yanez, Romana J R, Lamprecht, Renate, Granadillo, Milaid, Weber, Brandon, Torrens, Isis, Rybicki, Edward P, Hitzeroth, Inga I

Volltext

128MO Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarci... von Rha, S.Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J-P., Weber, P.E. Yanez, Wyrwicz, L.S., Shen, L., Ostapenko, Y.V., Bilici, M., Chung, H.C., Shitara, K., Mahave, M., van Cutsem, E., Tabernero, J., Xu, L., Sharan, K.P., Bhagia, P., Janjigian, Y.Y.

Volltext

1400O Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarci... von Janjigian, Y.Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J-P., Yanez Weber, P.E., Wyrwicz, L.S., Shen, L., Ostapenko, Y.V., Bilici, M., Chung, H.C., Shitara, K., Mahave, M., Van Cutsem, E., Tabernero, J., Xu, L., Sharan, K., Bhagia, P., Rha, S.Y.

Volltext

178P KEYNOTE-859 update: Pembrolizumab + chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer von Ryu, M.H., Rha, S.Y., Wyrwicz, L.S., Weber, P.E. Yanez, Bai, Y., Lee, J., Herrero, F. Rivera, Alves, G.V., Garrido, M., Shiu, K-K., Fernández, M. González, Li, J., Lowery, M.A., Cil, T., Cruz, F., Oh, D-Y., Yin, L., Bordia, S., Bhagia, P., Qin, S.

Volltext

130O The phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophage... von Rha, S.Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J-P., Yanez Weber, P.E., Wyrwicz, L.S., Shen, L., Ostapenko, Y.V., Bilici, M., Chung, H.C., Shitara, K., Qin, S., van Cutsem, E., Tabernero, J., Li, K., Shih, C-S., Bhagia, P., Janjigian, Y.Y.

Volltext

LBA3 Final analysis of the phase III KEYNOTE-585 study of pembrolizumab plus chemotherapy vs chemotherapy as perioperative therapy in locally-advanced gastric and gastroesophageal... von Shitara, K., Rha, S.Y., Wyrwicz, L.S., Oshima, T., Karaseva, N., Osipov, M., Yasui, H., Yabusaki, H., Afanasyev, S., Park, Y-K., Al-Batran, S-E., Yoshikawa, T., Yanez Weber, P.E., Di Bartolomeo, M., Lonardi, S., Fang, X., Shih, C-S., Bhagia, P., Bang, Y-J.

Volltext

1511O Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Survival results from the phase III, random... von Janjigian, Y.Y., Kawazoe, A., Bai, Y., Xu, J., Lonardi, S., Metges, J-P., Yanez Weber, P.E., Wyrwicz, L.S., Shen, L., Ostapenko, Y.V., Bilici, M., Chung, H.C., Shitara, K., Qin, S., Van Cutsem, E., Tabernero, J., Li, K., Shih, C-S., Bhagia, P., Rha, S.Y.

Volltext

LBA74 Pembrolizumab plus chemotherapy vs chemotherapy as neoadjuvant and adjuvant therapy in locally-advanced gastric and gastroesophageal junction cancer: The phase III KEYNOTE-58... von Shitara, K., Rha, S.Y., Wyrwicz, L.S., Oshima, T., Karaseva, N., Osipov, M., Yasui, H., Yabusaki, H., Afanasyev, S., Park, Y-K., Al-Batran, S-E., Yoshikawa, T., Yanez Weber, P.E., Di Bartolomeo, M., Lonardi, S., Fang, X., Shih, C-S., Bhagia, P., Bang, Y-J.

Volltext

1223P First-line lenvatinib (Len) + pembrolizumab (Pembro) + chemotherapy (Chemo) vs chemo in advanced/metastatic gastroesophageal adenocarcinoma: LEAP-015 safety run-in von Shitara, K., Ben-Aharon, I., Rojas, C., Acosta Eyzaguirre, D.A., Hubert, A., Araya Moya, H., Cohen, D., Bai, L-Y., Ghiringhelli, F., Wyrwicz, L., Janjigian, Y.Y., Tabernero, J., Van Cutsem, E., Qin, S., Xu, J., Wang, A., Miller, M.G., Shih, C-S., Bhagia, P., Yanez Weber, P.E.

Volltext